Cargando…

Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway

BACKGROUND: Zinc transporters have been found to be associated with the pathogenesis of numerous human diseases including cancer. As the most lethal gynecologic malignancy, ovarian cancer is characterized by rapid progression and widespread metastases. However, the function and underlying mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xinxin, Wang, Jie, Liu, Chunling, Jiang, Tianduo, Yang, Ningzhi, Liu, Dan, Zhao, Huanhuan, Xu, Zhelong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215834/
https://www.ncbi.nlm.nih.gov/pubmed/34154618
http://dx.doi.org/10.1186/s13046-021-01999-3
_version_ 1783710316221169664
author Cheng, Xinxin
Wang, Jie
Liu, Chunling
Jiang, Tianduo
Yang, Ningzhi
Liu, Dan
Zhao, Huanhuan
Xu, Zhelong
author_facet Cheng, Xinxin
Wang, Jie
Liu, Chunling
Jiang, Tianduo
Yang, Ningzhi
Liu, Dan
Zhao, Huanhuan
Xu, Zhelong
author_sort Cheng, Xinxin
collection PubMed
description BACKGROUND: Zinc transporters have been found to be associated with the pathogenesis of numerous human diseases including cancer. As the most lethal gynecologic malignancy, ovarian cancer is characterized by rapid progression and widespread metastases. However, the function and underlying mechanism of zinc transporters in ovarian cancer metastasis remain unclear. METHODS: The relationship between zinc transporter gene expressions and clinical outcomes of ovarian cancer was assessed with the online database Kaplan-Meier plotter (http://kmplot.com/analysis/). Immunohistochemistry was performed to investigate the prognostic importance of ZIP13. The expression of ZIP13 in ovarian cancer cell lines was depleted to explore its effect on proliferation, adhesion, migration, and invasion both in vitro and in vivo assays. RNA-Seq, quantitative RT-PCR, and western blot analysis were performed to explore ZIP13-regulated downstream target genes. RESULTS: The expressions of several zinc transporters were highly associated the clinical outcomes of ovarian cancer patients. Among them, high ZIP13 expression was an independent prognostic factor for poor survival in patients with ovarian cancer. ZIP13 knockout suppressed the malignant phenotypes of ovarian cancer cells both in vitro and in vivo. Further investigation revealed that ZIP13 regulated intracellular zinc distribution and then affected the expressions of genes involved in extracellular matrix organization and cytokine-mediated signaling pathway. This led to the activation of Src/FAK pathway with increased expressions of pro-metastatic genes but decreased expressions of tumor suppressor genes. CONCLUSIONS: ZIP13 is shown to be a novel driver of metastatic progression by modulating the Src/FAK signaling pathway, which may serve as a promising biomarker for prognostic evaluation and targeted therapy in ovarian cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01999-3.
format Online
Article
Text
id pubmed-8215834
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82158342021-06-23 Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway Cheng, Xinxin Wang, Jie Liu, Chunling Jiang, Tianduo Yang, Ningzhi Liu, Dan Zhao, Huanhuan Xu, Zhelong J Exp Clin Cancer Res Research BACKGROUND: Zinc transporters have been found to be associated with the pathogenesis of numerous human diseases including cancer. As the most lethal gynecologic malignancy, ovarian cancer is characterized by rapid progression and widespread metastases. However, the function and underlying mechanism of zinc transporters in ovarian cancer metastasis remain unclear. METHODS: The relationship between zinc transporter gene expressions and clinical outcomes of ovarian cancer was assessed with the online database Kaplan-Meier plotter (http://kmplot.com/analysis/). Immunohistochemistry was performed to investigate the prognostic importance of ZIP13. The expression of ZIP13 in ovarian cancer cell lines was depleted to explore its effect on proliferation, adhesion, migration, and invasion both in vitro and in vivo assays. RNA-Seq, quantitative RT-PCR, and western blot analysis were performed to explore ZIP13-regulated downstream target genes. RESULTS: The expressions of several zinc transporters were highly associated the clinical outcomes of ovarian cancer patients. Among them, high ZIP13 expression was an independent prognostic factor for poor survival in patients with ovarian cancer. ZIP13 knockout suppressed the malignant phenotypes of ovarian cancer cells both in vitro and in vivo. Further investigation revealed that ZIP13 regulated intracellular zinc distribution and then affected the expressions of genes involved in extracellular matrix organization and cytokine-mediated signaling pathway. This led to the activation of Src/FAK pathway with increased expressions of pro-metastatic genes but decreased expressions of tumor suppressor genes. CONCLUSIONS: ZIP13 is shown to be a novel driver of metastatic progression by modulating the Src/FAK signaling pathway, which may serve as a promising biomarker for prognostic evaluation and targeted therapy in ovarian cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01999-3. BioMed Central 2021-06-21 /pmc/articles/PMC8215834/ /pubmed/34154618 http://dx.doi.org/10.1186/s13046-021-01999-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cheng, Xinxin
Wang, Jie
Liu, Chunling
Jiang, Tianduo
Yang, Ningzhi
Liu, Dan
Zhao, Huanhuan
Xu, Zhelong
Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title_full Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title_fullStr Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title_full_unstemmed Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title_short Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
title_sort zinc transporter slc39a13/zip13 facilitates the metastasis of human ovarian cancer cells via activating src/fak signaling pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215834/
https://www.ncbi.nlm.nih.gov/pubmed/34154618
http://dx.doi.org/10.1186/s13046-021-01999-3
work_keys_str_mv AT chengxinxin zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT wangjie zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT liuchunling zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT jiangtianduo zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT yangningzhi zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT liudan zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT zhaohuanhuan zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway
AT xuzhelong zinctransporterslc39a13zip13facilitatesthemetastasisofhumanovariancancercellsviaactivatingsrcfaksignalingpathway